-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE 1-US FDA declines to approve Capricor's cell therapy for Duchenne muscular dystrophy; shares slump

Reuters·11/20/2026 23:44:27

Please log in to view news